Lungs News and Research

RSS

Aradigm reports net loss of $4.1M for second-quarter 2010

Aradigm Corporation today announced financial results for the second quarter and six months ended June 30, 2010.

12 Aug 2010

Early administration of TXA reduces death from bleeding without increase in complications: Study

If recently injured patients with serious bleeding were to receive a cheap, widely available and easily administered drug to help their blood to clot, tens of thousands of lives could be saved every year, according to a paper published on-line today by The Lancet.

12 Aug 2010

Ultrafine particle exposure may contribute to coronary heart disease risk in firefighters: Research

Exposure to high levels of ultrafine particles—invisible particles that can reach the smallest air passages in the lungs—may be an important contributor to the risk of coronary heart disease in firefighters, reports a study in the August Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

12 Aug 2010

LCA launches “National Shine a Light on Lung Cancer Vigil” to raise awareness

Today, Lung Cancer Alliance (LCA) announced the launch of the National Shine a Light on Lung Cancer Vigil to honor loved ones, raise awareness and provide hope, compassion and support for all those touched by lung cancer.

12 Aug 2010

Omega-3 fatty acids consumption reduces age-related hearing loss: Research

Research continues to unveil potential benefits of omega-3 fatty acids found in seafood, pointing to healthful effects on the lungs in children, the uterus in women and hearing in older adults. The August 2010 PUFA Newsletter and Fats of Life e-newsletters for health professionals and consumers, respectively, report the latest findings about these and other topics.

12 Aug 2010

Hospital staph infection rate drops as national prevention effort steps up

The rate of drug-resistant staph hospital-acquired infections has dropped as the U.S. has stepped up prevention efforts to fight the deadly condition, The Associated Press reports. "The decline was seen in a federal study of methicillin-resistant staph, or MRSA. The bug often causes only a boil or skin infection. But researchers in the study focused on invasive cases that can become deadly, invading the bloodstream, flesh, lungs and bones. Researchers found that in nine metro areas, cases of MRSA (MUR'-suh) fell about 16 percent between 2005 and 2008.

12 Aug 2010

College of Medicine receives grant to operate as data coordinating center for AsthmaNet research endeavor

The Penn State College of Medicine's Department of Public Health Sciences has received a grant of about $54 million over seven years to act as the data coordinating center for the National Heart Lung and Blood Institute's AsthmaNet. This grant is one of the largest in the college's history. AsthmaNet is a research collaboration of multiple clinical centers across the nation that conducts clinical trials to address new treatments and asthma management.

12 Aug 2010

Scientists find therapeutic potential of stem cells for acute lung injury

Researchers are reporting this week new study results they say provide further evidence of the therapeutic potential of stem cells derived from bone marrow for patients suffering from acute lung injury, one of the most common causes of respiratory failure in intensive care units.

12 Aug 2010

Study examines link between breath, cancer detection

A test using a patient's breath could be developed to detect lung, breast, bowel and prostate cancers, a team of scientists have discovered. While these results are only preliminary, the study1 published in the British Journal of Cancer today (Wednesday), found that sensors could distinguish between the breath of healthy patients and those who have cancer.

11 Aug 2010

Premier international conference to highlight understanding of cancer disparities

This year, the American Association for Cancer Research will host its third conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved at the Loews Miami Beach Hotel in Miami, Fla.

11 Aug 2010

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

11 Aug 2010

SMI/Omega development team receives fund to develop prototype fast multispectral endoscope

Cascade Technologies, Inc., announced today that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will receive NIH research funding through a collaboration with Omega Optical of Brattleboro, Vermont. This effort will accelerate development of a new class of medical endoscopes enhanced with proprietary multispectral imaging technology. The principal investigators on the project are Dr. Gary Carver, Director of Research at Omega Optical, and Dr. Daniel L. Farkas, Chairman and CEO of SMI.

11 Aug 2010

FDA approves longer Valcyte therapy for CMV disease in adult kidney transplant patients

Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) approved increasing the length of therapy with Valcyte (valganciclovir hydrochloride) in adult kidney transplant patients at high risk for cytomegalovirus (CMV) disease.

11 Aug 2010

ACT signs agreement to select novel clinical candidates for two cancer metabolic programs

Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, today announced that it has signed an exclusive agreement to leverage the translational research expertise of Dr. Jason Chesney, Associate Professor, Department of Medicine at the University of Louisville's James Graham Brown Cancer Center (Brown Cancer Center), to identify new clinical candidates for the prevention and treatment of cancers against two key cancer metabolic targets.

11 Aug 2010

Breath test to detect cancer: Study

According to researchers cancer may soon be detectable using a breath test. They are now developing sensors that can detect chemical markers of lung, breast, bowel and prostate cancer in a person's breath. The new portable device has been purported as an “electronic nose” that can detect early cancers. As a cancer grows, the surface of the cells emits chemicals. The research found that sensors – involving gold nanoparticles – could be used to detect these chemicals in the breath.

10 Aug 2010

Synta second-quarter net loss increases to $9.1 million

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results for the quarter ended June 30, 2010.

10 Aug 2010

Study on ethnic disparities in pediatric asthma in Latino and non-Latino children

A new study by researchers at the Bradley Hasbro Children's Research Center and the University of Puerto Rico may help explain some of the well-documented ethnic disparities in pediatric asthma.

10 Aug 2010

Poniard second-quarter net loss decreases to $6.5 million

Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today reported financial results for the second quarter ended June 30, 2010.

10 Aug 2010

Vena cava blood clot filters may cause potential life-threatening complications: Study

Two specific types of vena cava filters, devices used to prevent blood clots from reaching the lungs, appear to have evidence of fracturing inside the body, with some fractured fragments traveling to the heart and causing potentially life-threatening complications, according to a report posted online today that will appear in the November 8 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

10 Aug 2010

Scientist develops nano-methods to destroy tumors with fewer side effects

Though a valuable weapon against cancerous tumors, radiation therapy often harms healthy tissue as it tries to kill malignant cells. Now, Prof. Israel Gannot of Tel Aviv University's Department of Biomedical Engineering is developing a new way to destroy tumors with fewer side effects and minimal damage to surrounding tissue.

10 Aug 2010

Lungs News and Research

Aradigm reports net loss of $4.1M for second-quarter 2010

Early administration of TXA reduces death from bleeding without increase in complications: Study

Ultrafine particle exposure may contribute to coronary heart disease risk in firefighters: Research

LCA launches “National Shine a Light on Lung Cancer Vigil” to raise awareness

Omega-3 fatty acids consumption reduces age-related hearing loss: Research

Hospital staph infection rate drops as national prevention effort steps up

College of Medicine receives grant to operate as data coordinating center for AsthmaNet research endeavor

Scientists find therapeutic potential of stem cells for acute lung injury

Study examines link between breath, cancer detection

Premier international conference to highlight understanding of cancer disparities

Cord Blood America to begin sale of DNA Predisposition testing services

SMI/Omega development team receives fund to develop prototype fast multispectral endoscope

FDA approves longer Valcyte therapy for CMV disease in adult kidney transplant patients

ACT signs agreement to select novel clinical candidates for two cancer metabolic programs

Breath test to detect cancer: Study

Synta second-quarter net loss increases to $9.1 million

Study on ethnic disparities in pediatric asthma in Latino and non-Latino children

Poniard second-quarter net loss decreases to $6.5 million

Vena cava blood clot filters may cause potential life-threatening complications: Study

Scientist develops nano-methods to destroy tumors with fewer side effects

The ultimate guide to lung research tools and protocols eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News